Jasper Therapeutics (JSPR) Total Liabilities (2019 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Total Liabilities of $31.6 million for Q4 2025, up 73.54% year-over-year from $18.2 million in Q4 2024, and down 31.09% quarter-over-quarter from $45.9 million in Q3 2025.
Jasper Therapeutics (JSPR) Total Liabilities (2019 - 2025) Analysis & Trends
Jasper Therapeutics' Total Liabilities history runs 7 years deep, the most recent figure standing at $31.6 million for Q4 2025.
- In Q4 2025, Total Liabilities rose 73.54% year-over-year to $31.6 million; the TTM figure through Dec 2025 stood at $31.6 million (up 73.54% YoY), while the FY2025 annual figure was $31.6 million, up 73.54% from the prior year.
- Total Liabilities for Q4 2025 stood at $31.6 million, down from $45.9 million in the prior quarter.
- The five-year high for Total Liabilities was $45.9 million in Q3 2025, with the low at $11.1 million in Q1 2021.
- The 5-year median for Total Liabilities is $14.8 million (2021), against an average of $18.1 million.
- The sharpest annual moves came in 2021 and 2022: Total Liabilities surged 677.4% in 2021, then sank 59.65% in 2022.
- Jasper Therapeutics' Total Liabilities stood at $24.1 million in 2021, then slumped by 48.74% to $12.4 million in 2022, then jumped by 32.98% to $16.5 million in 2023, then rose by 10.78% to $18.2 million in 2024, then jumped by 73.54% to $31.6 million in 2025.
- Business Quant data shows JSPR's Total Liabilities at $31.6 million in Q4 2025, $45.9 million in Q3 2025, and $23.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 10.03 Bn |
| 10 | Jasper Therapeutics | 20.30 Mn | 20.30 Mn | - | 10.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 31.63 Mn |
| Sep 30, 2025 | 45.90 Mn |
| Jun 30, 2025 | 22.97 Mn |
| Mar 31, 2025 | 15.35 Mn |
| Dec 31, 2024 | 18.23 Mn |
| Sep 30, 2024 | 15.73 Mn |
| Jun 30, 2024 | 13.62 Mn |
| Mar 31, 2024 | 12.73 Mn |
| Dec 31, 2023 | 16.45 Mn |
| Sep 30, 2023 | 16.27 Mn |
| Jun 30, 2023 | 13.97 Mn |
| Mar 31, 2023 | 13.56 Mn |
| Dec 31, 2022 | 12.37 Mn |
| Sep 30, 2022 | 11.55 Mn |
| Jun 30, 2022 | 11.59 Mn |
| Mar 31, 2022 | 12.44 Mn |
| Dec 31, 2021 | 24.14 Mn |
| Sep 30, 2021 | 28.61 Mn |
| Jun 30, 2021 | 14.26 Mn |
| Mar 31, 2021 | 11.10 Mn |